An industry perspective of topical dermal bioequivalence

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 549-562

  McCleverty, Dawn ^a   Lyons, Richard ^a   Henry, Brian ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650370641     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. FDA Guidance for Industry. Draft Guidance, Topical Dermatological Drug Product NDAs and ANDAs-In Vivo Bioavailability, Bioequivalence, In Vitro Release and Associated Studies, June 1998 (withdrawn May 2002).
2. Chen M, Shah V, Patnaik R, et al. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res 2001; 18:1645-50.
3. FDA, Title 21 Code of Federal Regulations (CFR) Part 320.21, April 2005.
4. FDA Guidance for Industry. Nonsterile Semisolid Dosage Forms, Scale-Up and Postapproval Changes: Chemistry, Manufacturing and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation, May 1997.
5. FDA Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, March 2003.
6. FDA, Title 21 Code of Federal Regulations (CFR) Part 320.24, April 2005.
7. Shah V, Flynn G, Yacobi A, et al. Bioequivalence of topical dermatological dosage forms-methods of evaluation of bioequivalence. Pharm Res 1998; 15:167-71.
8. Bito L, Davson H, Levin E, et al. The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain and blood plasma of the dog. J Neurochem 1966; 13:1057-67.
9. Stahl M, Bouw B, Jackson A, et al. Human microdialysis. Curr Pharm Biotechnol 2002; 3:165-78.
10. Benveniste H, Hüttemeier P. Microdialysis-theory and application. Prog Neurobiol 1990; 3:195-215.
11. Elmquist W, Sawchuk R. Application of microdialysis in pharmacokinetic studies. Pharm Res 1997; 14:267-88.
12. Groth L. Cutaneous microdialysis-a new technique for the assessment of skin penetration. Curr Probl Dermatol 1998; 26:90-8.
13. Anderson C, Anderson T, Boman A. Cutaneous microdialysis of human in vivo dermal absorption studies. In:Robert MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment. 1st ed. New York: Marcel Dekker Inc., 1998;231-44.
14. Müller M. Microdialysis in clinical drug delivery studies. Adv Drug Deliv Rev 2000; 45:255-69.
15. de la Peña A, Liu P, Derendorf H. Microdialysis in peripheral tissues. Adv Drug Deliv Rev 2000; 45:189-216.
16. Pershing L, Bakhtian S, Poncelet C, et al. Comparison of skin stripping, in vitro release and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources. J Pharm Sci 2002; 91:1312-23.
17. Weigmann H, Lademann J, Schanzer S, et al. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol Appl Skin Physiol 2001; 14(Suppl. 1):98-102.
18. Benfeldt E, Serup J, Menné T. Microdialysis vs. suction blister technique for in vivo sampling of pharmacokinetics in the human dermis. Acta Derm Venereol 1999; 79:338-42.
19. FDA Guidance for Industry. Topical Dermatologic Corticosteroids: In Vivo Bioequivalence, June 1995.
20. Müller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57:371-80.
21. Kreilgaard K. Assessment of cutaneous drug delivery using microdialysis. Adv Drug Deliv Rev 2002; 54:S99-121.
22. Keene W. Evaluation of microdialysis as a tool for studying percutaneous drug absorption and cutaneous metabolism. PhD Thesis, Faculty of Medicine, University of Southampton, 2002.
23. Kreilgaard M, Kemme M, Burggraaf J, et al. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res 2001; 18:593-9.
24. Müller M, Mascher H, Kikuta C, et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62:293-9.
25. Benfeldt E, Serup J, Menné T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and noninvasive quantification of barrier function. Br J Dermatol 1999; 140:739-48.
26. Tegeder I, Muth-Selbach U, Lötsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999; 65:357-68.
27. Hegemann L, Forstinger C, Partsch B, et al. Microdialysis in cutaneous pharmacology:kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104:839-43.
28. Müller M, Rastelli C, Ferri P, et al. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25:1833-6.
29. Cross S, Anderson C, Roberts M. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol 1998; 46:29-35.
30. Cross S, Megwa S, Benson H, et al. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application. Pharm Res 1999; 16:427-33.